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We read with great interest the article by M. Vendette  and colleagues: “REM sleep behavior 
disorder predicts cognitive impairment in Parkinson disease without dementia.”1. We have 
been prospectively investigating non-demented Parkinson’s disease (PD) patients with 
polysomnography (PSG)-confirmed or excluded REM sleep behavior disorder (RBD) and 
cannot uniformly confirm an association of cognitive impairment with the presence of RBD in 
PD (see table 1). In a comprehensive neuropsychological assessment, PD patients with RBD 
had lower scores in figural fluency, in verbal and figural memory tests except for recognition, 
showed more difficulties in a visuo-spatial task and made more interference errors as in their 
study, but PD patients with RBD performed better in verbal fluency and with fewer 
perseverations in the Goldenberg test which evaluates concept learning and shifting. Also, no 
apraxia, visuoperceptual or other cortical deficits were found in either group, but no 
quantitative measures had been performed. Compared to matched healthy controls 
(unpublished data), our PD patients with and also without RBD showed a mild impairment in 
executive functions and in memory, which can already be observed in early stages of PD 2. In 
contrast, PD patients without RBD and healthy controls had similar test results in the study by 
Vendette and colleagues. Although statistical significance is lacking, which in some tests 
might be explained by the smaller number of subjects, and there are differences including 
other neuropsychological tests and a longer disease duration with more advanced motor 
impairment in our patients, these results underline the need for a larger prospective study to 
verify whether RBD is associated with cognitive impairment and predicts later development 
of dementia as the authors also have suggested. Yet, to confirm the second hypothesis, such a 
study would have to control for cognitive impairment as latter by itself predicts dementia. 
Neuropathological studies could clarify whether degeneration of brainstem nuclei which 
causes RBD 3 can also manifest with cognitive impairment. Conversely, the association of 
RBD and cognitive impairment may simply reflect a more widespread neurodegenerative 
process affecting brainstem and cortex which ultimately lead to dementia.  
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Table 1 Clinical characteristics and neuropsychological data  
 
RBD 
(n=12) 
 
 
No RBD 
(n=11) 
 
   p Statistical test
Age, y 63.50 ± 7.61   63.27 ± 8.74 0.95 t 
Age at onset, y 52.54 ± 10.11   55.95 ± 8.22 0.39 t 
Disease duration, m 136.83 ± 68.34    90.00 ± 50.41 0.08 t 
Hoehn-Yahr (on) 2.54 ± 0.14   2.36 ± 0.32 0.09 U 
Hoehn-Yahr (off) 2.71 ± 0.26   2.50 ± 0.55 0.04 U 
Therapy duration, m 109.83 ± 74.66    73.64 ± 47.71 0.18 t 
LED, mg 738.61 ± 448.56    1047.62 ± 401.03 0.10 t 
UPDRS III 24.42 ± 9.88 20.55 ± 6.77 0.29 t 
MMSE (0-30) 29.00 ± 1.21   29.55 ± 0.69 0.30 U 
Education, y 11.75 ± 4.05   13.00 ± 3.13 0.31 U 
Stroop III,s 36.17 ± 8.66   35.45 ± 6.65 0.83 t 
Stroop III (errors) 1.83 ± 1.70   1.09 ± 0.94 0.21 t 
Goldenberg I 21.63 ± 6.52   21.33 ± 9.22 0.95 t 
Goldenberg II 21.57 ± 8.28   16.00 ± 9.76 0.29 t 
Goldenberg II (perseveration) 2.14 ± 2.97   3.17 ± 3.19 0.56 t 
verbal fluency (3min, letter) 27.27 ± 11.35   24.91 ± 8.10 0.58 t 
verbal fluency (repetitions) 1.09 ± 1.64   1.00 ± 2.14 0.91 t 
verbal fluency (errors) 0.09 ± 0.30   1.00 ± 1.84 0.12 t 
figural fluency (3min, five point test) 19.92 ± 11.74    23.00 ± 10.83 0.52 t 
figural fluency (repetitions) 0.83 ± 1.27   0.64 ± 0.81 0.66 t 
figural fluency (errors) 0.08 ± 0.29   0.00 ± 0.00 0.35 t 
RAVLT (10 items, 3 series)  I-III 18.00 ± 3.62   21.36 ± 4.32 0.06 t 
RAVLT recall 4.08 ± 2.19   5.73 ± 2.94 0.14 t 
RAVLT recognition 9.00 ± 1.04   8.82 ± 1.99 0.78 t 
RVDLT (10 items, 3 series) I-III 14.50 ± 6.68   16.45 ± 5.68 0.46 t 
RVDLT recall 5.55 ± 2.46   5.91 ± 2.08 0.71 t 
RVDLT recognition 9.36 ± 3.29   8.45 ± 1.44 0.41 t 
Rey figure copy        28.20 ± 8.24   33.78 ± 3.27 0.08 t 
Rey figure recall       13.60 ± 5.38   17.78 ± 5.54 0.11 t 
 
Normality of distribution was tested. Unpaired t-tests (t) were used to compare parametric data between groups, and Mann-Whitney U test (U) for non-parametric data.  
 2 
m months, s seconds, y years, LED levodopa equivalent dosage, MMSE Mini-mental status examination (Folstein), RAVLT Rey Auditory Verbal Learning Test, RVDLT Rey 
Visual Design Learning Test, Rey Figure Rey-Osterrieth Complex Figure Test, UPDRS Unified Parkinson’s Disease Rating Scale 
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